Finnish Study Evaluates HPV Test as Primary Cervical Cancer Screening Tool | GenomeWeb

NEW YORK (GenomeWeb News) – Genetic testing for human papillomavirus or HPV followed by conventional cytology in HPV-positive women may be an effective primary cervical cancer screening method — particularly in women 35 or older — according to a paper published online today in the Journal of the National Cancer Institute.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.